ES2146389T3 - Derivados de 10-desacetilbaccatina iii y 10-desacetil-14beta-hidroxibaccatina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen. - Google Patents

Derivados de 10-desacetilbaccatina iii y 10-desacetil-14beta-hidroxibaccatina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2146389T3
ES2146389T3 ES96904100T ES96904100T ES2146389T3 ES 2146389 T3 ES2146389 T3 ES 2146389T3 ES 96904100 T ES96904100 T ES 96904100T ES 96904100 T ES96904100 T ES 96904100T ES 2146389 T3 ES2146389 T3 ES 2146389T3
Authority
ES
Spain
Prior art keywords
iii
derivatives
hidroxibaccatina
desacetilbaccatina
desacetil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96904100T
Other languages
English (en)
Inventor
Ezio Bombardelli
Bellis Paolo De
Bruno Gabetta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of ES2146389T3 publication Critical patent/ES2146389T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION TRATA DE NUEVOS DERIVADOS DE 10 DESACETILBACATINA III Y 10 III, QUE POSEEN ACTIVIDAD CITOTOXICA Y ANTI-TUMORAL. SE PREPARAN A PARTIR DE LOS LLAMADOS SINTONES U DE OTROS TAXANOS DE ORIGEN NATURAL, MEDIANTE LA OXIDACION SELECTIVA DEL HIDROXILO EN POSICION 10 PARA DAR UNA FUNCION CETO, Y LA POSTERIOR ESTERIFICACION EN LA POSICION 13, SI FUERA NECESARIO, CON CADENAS DE ISOSERINA SUSTITUIDAS DE FORMA VARIADA. LOS PRODUCTOS DE LA INVENCION PUEDEN ADMINISTRARSE MEDIANTE INYECCION O POR VIA ORAL, CUANDO SE FORMULAN DE FORMA ADECUADA.
ES96904100T 1995-03-17 1996-03-04 Derivados de 10-desacetilbaccatina iii y 10-desacetil-14beta-hidroxibaccatina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2146389T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI000533A IT1275936B1 (it) 1995-03-17 1995-03-17 Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni

Publications (1)

Publication Number Publication Date
ES2146389T3 true ES2146389T3 (es) 2000-08-01

Family

ID=11370949

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96904100T Expired - Lifetime ES2146389T3 (es) 1995-03-17 1996-03-04 Derivados de 10-desacetilbaccatina iii y 10-desacetil-14beta-hidroxibaccatina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.

Country Status (18)

Country Link
US (2) US5750562A (es)
EP (1) EP0815095B1 (es)
JP (4) JP4101289B2 (es)
KR (2) KR100388877B1 (es)
CN (2) CN1176914C (es)
AT (1) ATE193286T1 (es)
AU (1) AU705923B2 (es)
CA (1) CA2215682C (es)
DE (1) DE69608548T2 (es)
DK (1) DK0815095T3 (es)
ES (1) ES2146389T3 (es)
GR (1) GR3033742T3 (es)
HK (1) HK1005242A1 (es)
IT (1) IT1275936B1 (es)
NO (1) NO317056B1 (es)
PT (1) PT815095E (es)
RU (1) RU2152936C1 (es)
WO (1) WO1996029321A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283633B1 (it) * 1996-05-10 1998-04-23 Indena Spa Derivati tassanici loro sintesi e formulazioni che li contengono
ITMI991483A1 (it) * 1999-07-06 2001-01-06 Indena Spa Derivati tassanici e procedimenti per la loro preparazione
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
IT1318678B1 (it) * 2000-08-10 2003-08-27 Indena Spa Procedimento per la preparazione di derivati della baccatina iii.
ITMI20012186A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14-beta-idrossi-baccatina iii-1,14-carbonato
ITMI20012185A1 (it) * 2001-10-19 2003-04-19 Indena Spa Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
ATE377593T1 (de) 2003-09-25 2007-11-15 Tapestry Pharmaceuticals Inc 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung
RU2008142363A (ru) * 2006-03-27 2010-05-10 Тэпистри Фармасьютикалз, Инк. (Us) Конвергентный способ синтеза таксановых производных
EP2029563A4 (en) * 2006-06-12 2009-12-02 Canada Inc 6570763 SEMI-SYNTHETIC PATHWAY FOR THE PREPARATION OF PACLITAXEL, DOCETAXEL AND 10-DEACETYLBACCATINE III FROM 9-DIHYDRO-13-ACETYLBACCATINE III
US7847111B2 (en) 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
WO2008106621A1 (en) 2007-02-28 2008-09-04 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
ES2389518T3 (es) 2008-01-18 2012-10-26 Indena S.P.A. Formas sólidas de ortataxel

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380916A (en) * 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives
IT1254517B (it) * 1992-03-06 1995-09-25 Indena Spa 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
US5200534A (en) * 1992-03-13 1993-04-06 University Of Florida Process for the preparation of taxol and 10-deacetyltaxol
ATE136460T1 (de) * 1992-07-01 1996-04-15 Bristol Myers Squibb Co Fluor-taxole mit antitumor-wirkung
US5319112A (en) * 1992-08-18 1994-06-07 Virgnia Tech Intellectual Properties, Inc. Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
NO310238B1 (no) * 1992-12-24 2001-06-11 Bristol Myers Squibb Co Kjemiske forbindelser og farmasöytisk preparat samt anvendelse av slike preparater
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
IT1261667B (it) * 1993-05-20 1996-05-29 Tassano ad attivita' antitumorale.
ATE249448T1 (de) * 1993-06-11 2003-09-15 Upjohn Co Delta 6,7-taxol derivate antineoplastische verbindungen und diese enthaltende pharmazeutische zusammenstellungen
IL109926A (en) * 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
FR2707293A1 (fr) * 1993-07-08 1995-01-13 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
GR3033742T3 (en) 2000-10-31
JP2007137898A (ja) 2007-06-07
NO974266L (no) 1997-09-16
CA2215682C (en) 2008-01-29
EP0815095A1 (en) 1998-01-07
ITMI950533A0 (it) 1995-03-17
AU705923B2 (en) 1999-06-03
HK1005242A1 (en) 1998-12-31
CN1410421A (zh) 2003-04-16
EP0815095B1 (en) 2000-05-24
AU4832096A (en) 1996-10-08
PT815095E (pt) 2000-09-29
RU2152936C1 (ru) 2000-07-20
CA2215682A1 (en) 1996-09-26
US5973163A (en) 1999-10-26
ATE193286T1 (de) 2000-06-15
NO974266D0 (no) 1997-09-16
CN1176914C (zh) 2004-11-24
DE69608548D1 (de) 2000-06-29
DK0815095T3 (da) 2000-08-07
KR100388878B1 (ko) 2003-10-04
ITMI950533A1 (it) 1996-09-17
JP4101289B2 (ja) 2008-06-18
JP2011046744A (ja) 2011-03-10
CN100335470C (zh) 2007-09-05
IT1275936B1 (it) 1997-10-24
NO317056B1 (no) 2004-08-02
KR19980703031A (ko) 1998-09-05
WO1996029321A1 (en) 1996-09-26
KR100388877B1 (ko) 2003-06-25
JPH11502206A (ja) 1999-02-23
US5750562A (en) 1998-05-12
CN1178528A (zh) 1998-04-08
JP2012140465A (ja) 2012-07-26
DE69608548T2 (de) 2001-02-01

Similar Documents

Publication Publication Date Title
ES2146389T3 (es) Derivados de 10-desacetilbaccatina iii y 10-desacetil-14beta-hidroxibaccatina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
UY24192A1 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que los contienen
ES2126919T3 (es) Taxanos semisinteticos con actividad antitumoral.
KR970701507A (ko) 산화방지 효과를 갖는 천연물질을 함유한 담배와 유사한 담배제품 또는 담배물질 및 그의 제조
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
NO11062A (no) Farmasöytisk sammensetning og matvaresupplement
UY24386A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
ES2085454T3 (es) Agentes edulcorantes de clorodesoxiazucar estabilizados, en forma de polvo, y metodos para preparar los mismos.
AR003220A1 (es) Derivados acilados de melatonina; composicion farmaceutica y cosmetica y el uso de los mismos para la preparacion de un medicamento.
FI934548A (fi) En pappersarkmaterial foer ett aromatiskt aemne innehaollande roekningsprodukt
ATE235897T1 (de) Arzneimittel in form parenenteral verabreichbarer lipidmikropartikel
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
HUP0204157A2 (hu) Új 1,3-dihidro-2H-indol-2-on-származékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények
ATE338562T1 (de) Withania somnifera zusammensetzung
DK1233969T3 (da) Mono- og disaccharridderivater
ES2038442T3 (es) Inhibicion de la placa dental por agentes superficiactivos.
ES2042982T3 (es) Composicion oral.
AR018178A1 (es) Derivados de cromanona y tiocromanona, un proceso para su preparacion, una composicion farmaceutica que los comprende y el uso de los mismos para lapreparacion de un medicamento
CO5070569A1 (es) Compuesto de aminoazol o una sal farmaceuticamente aceptable del mismo y medicamento que los contienen
UY25356A1 (es) Polisacaridos de sintesis,procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9301014A (es) Composiciones citoprotectora y metodos para preparar y usar las mismas.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
AR020888A1 (es) Sustituto de crema, procedimiento para obtenerlo y productos que incluyen dicho sustituto
ES2148766T3 (es) Derivados de 10-desacetil-14beta-hidroxibaccatina iii, procedimiento para su preparacion y formulaciones que los contienen.
ES2088780T3 (es) Complejos de inclusion con silibinina, su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 815095

Country of ref document: ES